|
|
||||||||
a Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, Ohio
b Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio
c Department of Quantitative Health Sciences, The Cleveland Clinic, Cleveland, Ohio
Accepted for publication January 15, 2008.
* Address correspondence to Dr Smedira, Kaufman Center for Heart Failure, Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, 9500 Euclid Ave/F24, Cleveland, OH 44195 (Email: smedirn{at}ccf.org).
Background: Functional and intrinsic mitral valve (MV) abnormalities are common in hypertrophic cardiomyopathy (HCM); however, morphologic characteristics constituting indications for surgical intervention are incompletely defined. This study was conducted to define the echocardiographic features of MV pathology in patients with HCM and relate these to repairability of the MV, MV procedures performed, durability of repair, and survival.
Methods: From 1986 to 2003, 851 patients with HCM underwent operation, and 115 had a concomitant MV procedure. Detailed analysis of their 784 transthoracic and transesophageal echocardiograms, performed intraoperatively and postoperatively, was conducted. Outcomes were assessed by cross-sectional follow-up.
Results: Sixty-seven patients (58%) underwent MV repair, and 48 (42%) had MV replacement. The mean left ventricular outflow tract peak gradient was 70 ± 50 mm Hg. Systolic anterior motion was present in 95%. Valve abnormalities were degenerative in 36 (31%), myxomatous in 23 (20%), papillary muscle in 23 (20%), restrictive chordal in 22 (19%), restrictive leaflet in 80 (70%), and long leaflet in 64 (56%). Patients undergoing MV repair had higher prevalence of long leaflets and degenerative MV pathology. The anterior mitral leaflet was 3.0 ± 0.49 cm in the repair group vs 2.5 ± 0.40 cm in the replacement group (p = 0.0001). MV replacement patients were older, more symptomatic, and had more renal dysfunction and lower hematocrits. By 3 years, 91% of patients with a repair were free of reoperation.
Conclusions: Intrinsic MV pathology is frequently observed in HCM patients with symptomatic obstruction who undergo myectomy. Echocardiography can identify MV features predictive of successful valve repair. Repair, although durable, is feasible in only about half of patients.
Related Article
Ann. Thorac. Surg. 2008 85: 1536.
This article has been cited by other articles:
![]() |
P. Elliott The Role of Alcohol Septal Ablation in the Treatment of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., November 22, 2011; 58(22): 2329 - 2331. [Full Text] [PDF] |
||||
![]() |
A. T. Turer, Z. Samad, A. M. Valente, M. A. Parker, B. Hayes, R. J. Kim, J. Kisslo, and A. Wang Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy Eur Heart J Cardiovasc Imaging, February 1, 2011; 12(2): 131 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Kim, M. D. Handschumacher, R. A. Levine, Y.-S. Choi, Y. J. Kim, S.-C. Yun, J.-M. Song, D.-H. Kang, and J.-K. Song In Vivo Measurement of Mitral Leaflet Surface Area and Subvalvular Geometry in Patients With Asymmetrical Septal Hypertrophy: Insights Into the Mechanism of Outflow Tract Obstruction Circulation, September 28, 2010; 122(13): 1298 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kwon, N. G. Smedira, M. Thamilarasan, B. W. Lytle, H. Lever, and M. Y. Desai Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 317 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.K. Williams, M.P. Frenneaux, and R.P. Steeds Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management Eur Heart J Cardiovasc Imaging, December 1, 2009; 10(8): iii9 - iii14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K.N. Wan, J. A. Dearani, T. M. Sundt III, S. R. Ommen, and H. V. Schaff What Is the Best Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy and Degenerative Mitral Regurgitation? Ann. Thorac. Surg., September 1, 2009; 88(3): 727 - 732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |